日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / State Council News

Nation issues new anti-monopoly guidelines for pharma sector

By Li Jiaying | chinadaily.com.cn | Updated: 2025-01-24 21:04
Share
Share - WeChat
Pharmacists dispense drugs at a hospital in Huzhou, Zhejiang province, in August. YI FAN/FOR CHINA DAILY

In an effort to safeguard fair market competition and protect consumer interests, the State Council's anti-monopoly commission officially issued new anti-monopoly guidelines on Friday targeting the pharmaceutical sector. 

A key highlight of the guidelines lies in the involvement of online platforms' monopolistic regulations. Given the rapid growth of online medical consultations and pharmaceutical e-commerce, the guidelines, for the first time, incorporate measures to address monopolistic practices in online medicine businesses, prohibiting platforms from engaging in the misuse of data, algorithms or platform rules.

The broad scope of the new guidelines also merits attention, which encompasses the entire pharmaceutical product chain — including traditional Chinese medicine, chemical drugs and biological products — compared to the previous version, which was largely concentrated in the limited realm of chemical active pharmaceutical ingredients (APIs).

"The pharmaceutical industry is highly technology-driven. Besides APIs, it also includes innovative drugs, patented medicines and generics. Every stage — from procurement and R&D to production, distribution and generic development — involves significant technological advancements and related protective strategies," said Zhou Wei, deputy director of the health law research center at Wuhan University, in an earlier interview. 

To further combat "false innovation", the guidelines also address a new type of patent monopoly behavior known as "product hopping". 

Product hopping refers to a strategy employed by original drug manufacturers to avoid or reduce competition from generic drugs, which mostly occurs shortly before the expiration of a patented drug and the entry of its generic counterpart and if applied inappropriately, could constitute an abuse of market dominance.

Factors for evaluation include whether the new patented drug represents a non-substantial improvement and whether the transition hinders or delays the entry of generics into the market, according to the guidelines.

"This is not about restricting the development of patented drugs but about regulating false innovation that fails to significantly improve a drug's efficacy, safety or utility," Zhou said.

Comprising seven chapters and 55 articles, the guidelines aim to provide detailed interpretations of monopolistic practices, enforcement principles and criteria for determining violations, offering a comprehensive framework to tackle anti-competitive behaviors in the pharmaceutical industry.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 日韩精品a在线视频 | 一级一级毛片免费看 | 日本三级韩国三级香港三级 | 日韩在线1 | 亚洲精品久| 啪啪激情婷婷久久婷婷色五月 | 日日夜夜爱 | 久久伊人色综合 | 波多野吉衣在线观看 | 成人观看网站a | 日韩丝袜在线观看 | 亚洲人人| 激情五月色综合婷婷大片 | 免费av电影网站 | 午夜色视频在线观看 | 国产区久久 | 国产一区二区三区在线免费观看 | 亚洲精品在线免费 | 在线观看亚洲a | 夜夜操网| 一区二区免费在线观看 | 欧美不卡视频 | 成人伊人网| 99视频这里只有精品国产 | 国产视频高清在线 | 天天弄天天干 | 91免费永久国产在线观看 | 一区二区高清 | 欧美成人一级片 | 精品欧美一区二区三区久久久 | 男女视频免费在线观看 | 国产在线精品一区二区三区 | 免费国产va在线观看视频 | 亚洲www啪成人一区二区麻豆 | 色综合久久天天综合网 | 精品无码中出一区二区 | 99影视在线视频免费观看 | 日韩精品在线播放 | 中文字幕在线综合 | 又黄又爽的成人免费网站 | 国产成人免费视频网站视频社区 |